Marizyme, Inc.
MRZM
$0.0003
-$0.0078-96.30%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 183.50K | 365.00K | 549.70K | 645.80K | 590.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 183.50K | 365.00K | 549.70K | 645.80K | 590.90K |
| Cost of Revenue | 67.40K | 131.40K | 343.10K | 407.00K | 379.00K |
| Gross Profit | 116.10K | 233.60K | 206.70K | 238.90K | 212.00K |
| SG&A Expenses | 10.57M | 13.94M | 16.66M | 17.06M | 10.84M |
| Depreciation & Amortization | 549.20K | 650.70K | 739.70K | 841.20K | 841.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.55M | 16.23M | 19.63M | 20.49M | 14.53M |
| Operating Income | -12.36M | -15.87M | -19.08M | -19.84M | -13.94M |
| Income Before Tax | -24.56M | -49.14M | -78.62M | -74.95M | -88.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.56 | -49.14 | -78.62 | -74.95 | -88.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.56M | -49.14M | -78.62M | -74.95M | -88.75M |
| EBIT | -12.36M | -15.87M | -19.08M | -19.84M | -13.94M |
| EBITDA | -11.82M | -15.22M | -18.34M | -19.00M | -13.10M |
| EPS Basic | -0.30 | -0.86 | -1.65 | -1.66 | -2.06 |
| Normalized Basic EPS | -0.01 | -0.28 | -0.47 | -0.48 | -0.52 |
| EPS Diluted | -0.30 | -0.87 | -1.65 | -1.67 | -2.06 |
| Normalized Diluted EPS | -0.01 | -0.28 | -0.47 | -0.48 | -0.52 |
| Average Basic Shares Outstanding | 447.46M | 361.48M | 272.93M | 181.89M | 170.43M |
| Average Diluted Shares Outstanding | 447.46M | 361.48M | 272.93M | 181.89M | 170.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |